HALO logo

Halozyme Therapeutics, Inc. (HALO) Net margin

annual net margin:

43.74%+9.78%(+28.80%)
December 31, 2024

Summary

  • As of today (September 5, 2025), HALO annual net profit margin is 43.74%, with the most recent change of +9.78% (+28.80%) on December 31, 2024.
  • During the last 3 years, HALO annual net margin has fallen by -47.10% (-51.85%).
  • HALO annual net margin is now -51.85% below its all-time high of 90.84%, reached on December 31, 2021.

Performance

1-year change

+28.8%

3-year change

-51.85%

5-year change

+218.67%

15-year change

+119.91%

HALO Net margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

99.4%
HALO annual net profit margin is higher than 99.4% of companies in Healthcare sector

Range

All-time high

90.84%
HALO annual net profit margin is currently -51.85% below its historical high of 90.84%

3-year low

30.62%
HALO annual net profit margin is currently +42.85% above its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
HALO previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
HALO next annual earnings announcement has not yet been scheduled

OtherHALOprofitability metrics

annual net income

$444.09M
HALO annual net profit is $444.09 million

Annual revenue

$1.02B
HALO annual revenue is $1.02 billion

annual gross margin

77.30%
HALO annual gross profit margin is 77.30%

Annual EPS

$3.43
HALO annual earnings per share is $3.43

Quarterly net margin:

50.71%+6.12%(+13.73%)
June 30, 2025

Summary

  • As of today (September 5, 2025), HALO quarterly net profit margin is 50.71%, with the most recent change of +6.12% (+13.73%) on June 30, 2025.
  • Over the past year, HALO quarterly net margin has increased by +10.41% (+25.83%).
  • HALO quarterly net margin is now -24.34% below its all-time high of 67.02%, reached on June 30, 2021.

Performance

3-month change

+13.73%

1-year change

+25.83%

3-year change

+240.56%

5-year change

+8.47%

HALO Quarterly net margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

98.77%
HALO quarterly net profit margin is higher than 98.77% of companies in Healthcare sector

Range

All-time high

67.02%
HALO quarterly net profit margin is currently -24.34% below its historical high of 67.02%

3-year low

14.89%
HALO quarterly net profit margin is currently +240.56% above its 3-year low

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
HALO previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Oct 28, 2025
HALO next earnings announcement is scheduled for Oct 28, 2025

OtherHALOprofitability metrics

quarterly net income

$165.16M
HALO quarterly net profit is $165.16 million

Quarterly revenue

$325.72M
HALO quarterly revenue is $325.72 million

quarterly gross margin

80.31%
HALO quarterly gross profit margin is 80.31%

Quarterly EPS

$1.33
HALO quarterly earnings per share is $1.33

Net margin Formula

Net Margin =  Net Income
Revenue ✕ 100%

annual net margin

43.74%
HALO annual net profit margin is 43.74%

annual net income

$444.09M
HALO annual net profit is $444.09 million

Annual revenue

$1.02B
HALO annual revenue is $1.02 billion

HALO Net margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+28.8%+25.8%
3 y3 years-51.9%+240.6%
5 y5 years+218.7%+8.5%

HALO Net margin Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-51.9%+42.9%at high+240.6%
5 y5-year-51.9%+218.7%-24.3%+240.6%
alltimeall time-51.9%+100.4%-24.3%+100.3%

HALO Net margin History

DateAnnualQuarterly
Jun 2025
-
50.71%(+13.7%)
Mar 2025
-
44.59%(-3.0%)
Dec 2024
43.74%(+28.8%)
45.98%(-2.6%)
Sep 2024
-
47.23%(+17.2%)
Jun 2024
-
40.30%(+2.8%)
Mar 2024
-
39.22%(+5.7%)
Dec 2023
33.96%(+10.9%)
37.12%(-2.0%)
Sep 2023
-
37.88%(+12.0%)
Jun 2023
-
33.82%(+38.4%)
Mar 2023
-
24.43%(-23.2%)
Dec 2022
30.62%(-66.3%)
31.79%(+7.8%)
Sep 2022
-
29.49%(+98.1%)
Jun 2022
-
14.89%(-70.9%)
Mar 2022
-
51.25%(-21.7%)
Dec 2021
90.84%(+88.3%)
65.46%(-2.3%)
Jun 2021
-
67.02%(+113.8%)
Mar 2021
-
31.34%(-47.9%)
Dec 2020
48.24%(-230.9%)
60.12%(+8.5%)
Sep 2020
-
55.43%(+18.6%)
Jun 2020
-
46.75%(-294.2%)
Mar 2020
-
-24.07%(-62.4%)
Dec 2019
-36.86%(-30.3%)
-64.10%(+18.5%)
Sep 2019
-
-54.11%(+44.8%)
Jun 2019
-
-37.36%(-1286.0%)
Mar 2019
-
3.15%(-189.2%)
Dec 2018
-52.90%(-366.0%)
-3.53%(-96.8%)
Sep 2018
-
-108.98%(+67.6%)
Jun 2018
-
-65.03%(-26.9%)
Mar 2018
-
-88.95%(-236.1%)
Dec 2017
19.89%(-128.3%)
65.35%(+1416.2%)
Sep 2017
-
4.31%(-104.7%)
Jun 2017
-
-91.15%(-18.1%)
Mar 2017
-
-111.26%(+58.4%)
Dec 2016
-70.23%(+194.3%)
-70.22%(-22.7%)
Sep 2016
-
-90.87%(+12.7%)
Jun 2016
-
-80.62%(+72.9%)
Mar 2016
-
-46.63%(-663.8%)
Dec 2015
-23.86%(-73.7%)
8.27%(-107.0%)
Sep 2015
-
-117.71%(-1791.2%)
Jun 2015
-
6.96%(-108.6%)
Mar 2015
-
-80.94%(+366.2%)
Dec 2014
-90.76%
-17.36%(-87.5%)
Sep 2014
-
-138.85%(+56.9%)
Jun 2014
-
-88.51%(-60.1%)
DateAnnualQuarterly
Mar 2014
-
-221.86%(+26.1%)
Dec 2013
-152.33%(+20.4%)
-175.91%(+46.0%)
Sep 2013
-
-120.48%(-24.0%)
Jun 2013
-
-158.52%(-2.7%)
Mar 2013
-
-163.00%(+706.1%)
Dec 2012
-126.53%(+259.0%)
-20.22%(-94.6%)
Sep 2012
-
-375.04%(+107.5%)
Jun 2012
-
-180.75%(-11.1%)
Mar 2012
-
-203.21%(-73.4%)
Dec 2011
-35.25%(-91.0%)
-763.75%(-3492.9%)
Sep 2011
-
22.51%(+67.5%)
Jun 2011
-
13.44%(-110.5%)
Mar 2011
-
-127.73%(-73.0%)
Dec 2010
-390.79%(-8.5%)
-472.88%(+29.4%)
Sep 2010
-
-365.36%(-3.4%)
Jun 2010
-
-378.13%(+10.4%)
Mar 2010
-
-342.49%(+74.3%)
Dec 2009
-426.88%(-23.1%)
-196.54%(-57.2%)
Sep 2009
-
-459.25%(-61.6%)
Jun 2009
-
-1196.19%(+125.2%)
Mar 2009
-
-531.14%(-3.3%)
Dec 2008
-555.15%(-11.7%)
-549.46%(+24.4%)
Sep 2008
-
-441.56%(-42.4%)
Jun 2008
-
-767.15%(+39.1%)
Mar 2008
-
-551.32%(-15.3%)
Dec 2007
-628.93%(-58.1%)
-650.90%(-12.7%)
Sep 2007
-
-745.44%(+10.0%)
Jun 2007
-
-677.73%(+63.6%)
Mar 2007
-
-414.38%(-59.7%)
Dec 2006
-1502.70%(-85.6%)
-1026.98%(+2.0%)
Sep 2006
-
-1007.17%(-62.7%)
Jun 2006
-
-2700.75%(-43.3%)
Mar 2006
-
-4761.53%(-24.2%)
Dec 2005
-10.44K%(+3290.9%)
-6285.33%(-56.5%)
Sep 2005
-
-14.46K%(+130.3%)
Jun 2005
-
-6276.37%(+167.8%)
Dec 2003
-307.78%(+313.8%)
-2343.48%(+3008.1%)
Sep 2003
-
-75.40%(+25.7%)
Jun 2003
-
-60.00%(-83.0%)
Mar 2003
-
-353.57%(+164.2%)
Dec 2002
-74.37%(-53.7%)
-133.82%(+77.4%)
Sep 2002
-
-75.45%(-63.4%)
Jun 2002
-
-206.41%(-734.5%)
Mar 2002
-
32.53%
Dec 2001
-160.73%
-

FAQ

  • What is Halozyme Therapeutics, Inc. annual net profit margin?
  • What is the all time high annual net margin for Halozyme Therapeutics, Inc.?
  • What is Halozyme Therapeutics, Inc. annual net margin year-on-year change?
  • What is Halozyme Therapeutics, Inc. quarterly net profit margin?
  • What is the all time high quarterly net margin for Halozyme Therapeutics, Inc.?
  • What is Halozyme Therapeutics, Inc. quarterly net margin year-on-year change?

What is Halozyme Therapeutics, Inc. annual net profit margin?

The current annual net margin of HALO is 43.74%

What is the all time high annual net margin for Halozyme Therapeutics, Inc.?

Halozyme Therapeutics, Inc. all-time high annual net profit margin is 90.84%

What is Halozyme Therapeutics, Inc. annual net margin year-on-year change?

Over the past year, HALO annual net profit margin has changed by +9.78% (+28.80%)

What is Halozyme Therapeutics, Inc. quarterly net profit margin?

The current quarterly net margin of HALO is 50.71%

What is the all time high quarterly net margin for Halozyme Therapeutics, Inc.?

Halozyme Therapeutics, Inc. all-time high quarterly net profit margin is 67.02%

What is Halozyme Therapeutics, Inc. quarterly net margin year-on-year change?

Over the past year, HALO quarterly net profit margin has changed by +10.41% (+25.83%)
On this page